Is SoFi Stock a Buy Under $20?
After briefly flirting with penny‑stock territory during the 2022 bear…
Sell
16
APVO Quote, Financials, Valuation and Earnings
Last price:
$3.08
Seasonality move
:
-25.73%
Day range:
$3.03 - $3.23
52-week range:
$2.81 - $485.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.10x
Volume:
308.2K
Avg. volume:
4.7M
1-year change:
-99.19%
Market cap:
$2.1M
Revenue:
--
EPS (TTM):
-$1,596.48
Aptevo Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
APVO
Aptevo Therapeutics
|
11/14/2023 | 10-Q | 10-Q filing on 11/14/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
08/10/2023 | 10-Q | 10-Q filing on 08/10/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
05/11/2023 | 10-Q | 10-Q filing on 05/11/2023 | View Form |
|
APVO
Aptevo Therapeutics
|
11/10/2022 | 10-Q | 10-Q filing on 11/10/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
08/11/2022 | 10-Q | 10-Q filing on 08/11/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
05/12/2022 | 10-Q | 10-Q filing on 05/12/2022 | View Form |
|
APVO
Aptevo Therapeutics
|
11/12/2021 | 10-Q | 10-Q filing on 11/12/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
08/12/2021 | 10-Q | 10-Q filing on 08/12/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
05/11/2021 | 10-Q | 10-Q filing on 05/11/2021 | View Form |
|
APVO
Aptevo Therapeutics
|
11/10/2020 | 10-Q | 10-Q filing on 11/10/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
08/14/2020 | 10-Q | 10-Q filing on 08/14/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
05/13/2020 | 10-Q | 10-Q filing on 05/13/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
03/25/2020 | 10-K | 10-K filing on 03/25/2020 | View Form |
|
APVO
Aptevo Therapeutics
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
03/18/2019 | 10-K | 10-K filing on 03/18/2019 | View Form |
|
APVO
Aptevo Therapeutics
|
11/14/2018 | 10-Q | 10-Q filing on 11/14/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
07/27/2018 | 10-K | 10-K filing on 07/27/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
03/13/2018 | 10-K | 10-K filing on 03/13/2018 | View Form |
|
APVO
Aptevo Therapeutics
|
11/13/2017 | 10-Q | 10-Q filing on 11/13/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
05/12/2017 | 10-Q | 10-Q filing on 05/12/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
03/31/2017 | 10-K | 10-K filing on 03/31/2017 | View Form |
|
APVO
Aptevo Therapeutics
|
11/14/2016 | 10-Q | 10-Q filing on 11/14/2016 | View Form |
|
APVO
Aptevo Therapeutics
|
09/22/2016 | 10-Q | 10-Q filing on 09/22/2016 | View Form |
|
APVO
Aptevo Therapeutics
|
08/25/2016 | 10-Q | 10-Q filing on 08/25/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Apple Stock Not Joining the Broader Market Rally?
The S&P 500 has sprinted 4.92% higher so far in…
Will Google Stock Double by 2030?
If you bought Alphabet (NASDAQ: GOOGL) when Gmail launched in…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 54x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
NKE alert for Jun 30
Nike [NKE] is down 2.3% over the past day.
Buy
81
KTOS alert for Jun 30
Kratos Defense & Security Solutions [KTOS] is up 0.7% over the past day.
Sell
44
GDXU alert for Jun 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 2.57% over the past day.
